Senores Pharmaceuticals Limited — Updates, 26-08-2026: General Updates

Senores Pharma strengthened governance with a new CS & Compliance Officer and an Independent Director. The Board approved an Employee Stock Option Scheme (ESOS 2026) covering 4.72 lakh options (1% diluted equity). Strategic international expansion is underway with new subsidiaries planned for Mexico (Wholly Owned) and Canada (majority stake).